cell panel data analysis and interpretation (Oncolead Inc)
90
Structured Review
Oncolead Inc
cell panel data analysis and interpretation
Cell Panel Data Analysis And Interpretation, supplied by Oncolead Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+panel+data+analysis+and+interpretation/cell+panel+data+analysis+and+interpretation/pm36178776-548-9-5
Average 90 stars, based on 1 article reviews
Cell Panel Data Analysis And Interpretation, supplied by Oncolead Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+panel+data+analysis+and+interpretation/cell+panel+data+analysis+and+interpretation/pm36178776-548-9-5
Average 90 stars, based on 1 article reviews
cell panel data analysis and interpretation - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib. Article Snippet: Addressing resistance to third-generation EGFR TKIs such as osimertinib via the EGFRC797S mutation remains a highly unmet need in EGFR-driven non-small-cell lung cancer (NSCLC).. Herein, we present the discovery of the allosteric EGFR inhibitor 57, a novel fourth-generation inhibitor to overcome EGFRC797S-mediated resistance in patients harboring the activating EGFRL858R mutation.. 57 exhibits an improved potency compared to previous allosteric EGFR inhibitors. |